Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: SRI INTERNATIONAL
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-07-27 to 2022-11-30
Current total value of award: $381002
Description: CONTRACT #HHSN272201800001I; SRI INTERNATIONAL; GMP MANUFACTURING OF OXFENDAZOLE CLINICAL TRIAL MATERIAL AND STABILITY STUDY; OA TASK 75N93021F00006; MIS TASK TOIA21C13PIPB-1; BASE AWARD; CAN 8470036; TOTAL $381,002.00